Drug reaction with eosinophilia and systemic symptoms: Manifestations, treatment, and outcome in 17 patients

International Journal of Dermatology

Volumn 54, Issue 5, 2015, Pages 537-542

  Sultan, Sheikh Javeed ^a   Sameem, Farah ^a   Ashraf, Mohd ^b  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

^b GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALLOPURINOL; ASPARTATE AMINOTRANSFERASE; CARBAMAZEPINE; CREATININE; DAPSONE; DEXAMETHASONE; LAMOTRIGINE; LEFLUNOMIDE; NITROFURANTOIN; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREDNISOLONE; UREA; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHEILITIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DISEASE COURSE; DRESS SYNDROME; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EOSINOPHILIA; ERYTHEMA; ERYTHRODERMA; FACE EDEMA; FEMALE; FEVER; FOOT EDEMA; HEMATURIA; HEPATOMEGALY; HUMAN; HYPERBILIRUBINEMIA; HYPOTENSION; KIDNEY FAILURE; LATENT PERIOD; LEUKOCYTOSIS; LIVER FAILURE; LIVER FUNCTION TEST; LYMPHADENOPATHY; LYMPHOCYTOSIS; MACULOPAPULAR RASH; MALE; OUTCOME ASSESSMENT; POSTINFLAMMATORY HYPERPIGMENTATION; PROTEINURIA; PRURITUS; PUSTULE; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SYSTEMIC THERAPY; TACHYCARDIA; THROMBOCYTOPENIA; TREATMENT RESPONSE; COMPLICATION; DRUG HYPERSENSITIVITY SYNDROME; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; DRUG HYPERSENSITIVITY SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84928356030     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12331     Document Type: Article

References (41)

1. Bachot N, Roujeau JC. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol 2003; 4: 561-572.
2. Kumari R, Timshina DK, Thappa DM. Drug hypersensitivity syndrome. Indian J Dermatol Venereol Leprol 2011; 77: 7-15.
3. Sullivan JR, Shear NH. The drug hypersensitivity syndrome. What is the pathogenesis? Arch Dermatol 2001; 137: 357-364.
4. Callot V, Roujeau JC, Bagot M, et al. Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol 1996; 132: 1315-1321.
5. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms [DRESS]). Semin Cutan Med Surg 1996; 15: 250-257.
6. Walsh SA, Creamer D. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clin Exp Dermatol 2010; 36: 6-11.
7. Sontheimer RD, Houpt KR. DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome. Arch Dermatol 1998; 134: 874-875.
8. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. New Engl J Med 1994; 331: 1272-1285.
9. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. J Clin Invest 1988; 82: 1826-1832.
10. Peyrière H, Dereure O, Breton H, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2006; 155: 422-428.
11. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007; 156: 609-611.
12. Taliercio CP, Olney BA, Lie JT. Myocarditis related to drug hypersensitivity. Mayo Clin Proc 1986; 60: 463-468.
13. Engel JN, Mellul VG, Goodman OB. Phenytoin hypersensitivity: a case of severe acute rhabdomyolysis. Am J Med 1986; 81: 928-930.
14. Fujino Y, Nakajima M, Inoue H, et al. Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome. Ann Neurol 2002; 51: 771-774.
15. Sekine N, Motokura T, Oki T, et al. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA 2001; 285: 1153-1154.
16. Laban E, Hainaut-Wierzbicka E, Pourreau F, et al. Cyclophosphamide therapy for corticoresistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a patient with severe kidney and eye involvement and Epstein-Barr virus reactivation. Am J Kidney Dis 2010; 55: e11-e14.
17. Proudfoot LE, Watson K, Higgins EM, et al. Twenty cases of DRESS syndrome: culprits, clinical features, treatment and outcome. Br J Dermatol 2009; 161(SUPPL. 1): 5.
18. Shear N, Spielberg S, Grant D. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 1986; 105: 179-184.
19. Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS). A reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 2006; 55: 1-8.
20. Shiohara T, Iijima M, Ikezawa Z, et al. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007; 156: 1083-1084.
21. Hung SI, Chung WH, Liou LB, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005; 102: 4134-4139.
22. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245.
23. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 209: 123-129.
24. Eshki M, Allanore L, Musette P, et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multi-organ failure. Arch Dermatol 2009; 145: 67-72.
25. Chiou CC, Yang LC, Hung SI, et al. Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol 2008; 22: 1044-1049.
26. Powers NG, Carson NH. Idiosyncratic reactions to phenytoin. Clin Pediatr 1987; 25: 120-124.
27. Schlienger RG, Shear NH. Antiepileptic drug hypersensitivity syndrome. Epilepsia 1998; 39(SUPPL.): 3-7.
28. Um SJ, Lee SK, Kim YH, et al. Clinical features of drug-induced hypersensitivity syndrome in 38 patients. J Investig Allergol Clin Immunol 2010; 20: 556-562.
29. Kaminsky A, Moreno M, Diaz M, et al. Anticonvulsant hypersensitivity syndrome. Int J Dermatol 2005; 44: 594-598.
30. Natkunarajah J, Goolamali S, Craythorne E, et al. Ten cases of drug reaction with eosinophilia and systemic symptoms (DRESS) treated with pulsed intravenous methylprednisolone. Eur J Dermatol 2011; 21: 385-391.
31. Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology 2003; 206: 353-356.
32. Roujeau JC. Treatment of severe drug eruptions. J Dermatol 1999; 26: 718-722.
33. Zuliani E, Zwahlen H, Gilliet F, et al. Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment. Clin Nephrol 2005; 64: 155-158.
34. Harman KE, Morris SD, Higgins EM. Persistent anticonvulsant hypersensitivity syndrome responding to cyclosporin. Clin Exp Dermatol 2003; 28: 364-365.
35. Kito Y, Ito T, Tokura Y, et al. High-dose intravenous immunoglobulin monotherapy for drug-induced hypersensitivity syndrome. Acta Derm Venereol 2012; 92: 100-101.
36. Redondo P, de Felipe I, de la Pena A, et al. Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis: treatment with N-acetylcysteine. Br J Dermatol 1997; 136: 645-646.
37. De Vries A, Philippe J, van Renterghem D, et al. Carbamazepine hypersensitivity syndrome: report of four cases and review of the literature. Medicine 1995; 74: 144-151.
38. Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995; 155: 2285-2290.
39. Chopra S, Levell NJ, Cowley G, et al. Systemic corticosteroids in the phenytoin hypersensitivity syndrome. Br J Dermatol 1996; 134: 1109-1112.
40. Chen YC, Chu CY, Chiu HS. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol 2010; 146: 1373-1379.
41. Wei CH, Chung-Yee Hui R, Lin YJ, et al. Identifying prognostic factors for drug rash with eosinophilia and systemic symptoms (DRESS). Eur J Dermatol 2011; 21: 930-937.